Employers’ most commonly offered digital health benefits address health issues that employees rarely report as top health goals, according to a new report.
Benefit design and pricing
HHS Secretary Alex M. Azar II lays out top four HHS initiatives and calls on payers and providers to align.
The National Pharmaceutical Council takes issue with ICER’s collaboration with the VA’s PBM. Find out what both camps are saying.
While these types of programs have been in place for several years, it can be difficult to gauge who is using them and how, and whether they are achieving their intended goal.
Payers’ biggest concerns for 2018, health insurance exchange participation plans, and how offerings could change.
FDA incentives have hastened the development of “orphan drugs” for rare diseases, but some worry that regulators are not always demanding clear evidence for drug efficacy.
A University of Massachusetts clinical consulting pharmacist shows how assessing budget implications can be accomplished.
Here’s how to take consumer-centricity more seriously as expectations increase.
Learn from hospitals and managed care organizations at the forefront of successful initiatives. Read more.
Finding ways to communicate directly with and provide tailored services to LGBT individuals has been a challenge for managed care organizations, but experts say breaking barriers is imperative.